Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page
- ChecktodayChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6, indicating a new page revision. The visible study details appear unchanged by this metadata update.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, signaling a backend update rather than a modification to the study details.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision changed from v3.6.3 to v3.6.4 on the study page, indicating a patch-level update to the page framework. There is no indication that study content such as enrollment, results, or eligibility criteria has been altered.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a new release of the site content or backend. This change does not modify the study data or visible content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page revision label changed from v3.6.0 to v3.6.2 in the site metadata. This reflects a software update to the page, without altering the study details.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now states that no participants are being sought, signaling closed recruitment. It also adds quick-access sections such as How to Read a Study Record, Common Questions, How to Join a Study, and updates the Intervention/Treatment heading along with a site revision note (v3.6.0).SummaryDifference0.4%

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.